Natus Medical traded at $32.75 this Friday July 1st, decreasing $0.02 or 0.06 percent since the previous trading session. Looking back, over the last four weeks, Natus Medical lost 0.12 percent. Over the last 12 months, its price rose by 23.40 percent. Looking ahead, we forecast Natus Medical to be priced at 31.77 by the end of this quarter and at 29.28 in one year, according to Trading Economics global macro models projections and analysts expectations.

Stock Price
32.75
Daily Change
-0.06%
Yearly
23.40%

Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Peers Price Day Year
Abiomed 249.79 2.28 0.92% -21.21%
AngioDynamics 19.34 -0.01 -0.05% -29.39%
Accuray 1.93 -0.04 -1.79% -57.69%
AtriCure 40.70 -0.16 -0.39% -49.77%
Natus Medical 32.75 -0.02 -0.06% 23.40%
Boston Scientific 37.33 0.06 0.16% -15.00%
Cooper Companies 315.95 2.83 0.90% -22.51%
Artivion Inc 19.09 0.21 1.11% -32.23%
Cardiovascular Systems 14.51 0.15 1.04% -65.99%
Edwards Lifesciences 95.66 0.57 0.60% -10.25%
General Electric 62.90 -0.77 -1.21% -41.15%
Globus Medical 56.23 0.09 0.16% -28.61%
Integra LifeSciences 54.17 0.14 0.26% -22.50%
Inogen 24.07 -0.11 -0.45% -62.47%
Masimo 133.77 3.10 2.37% -46.92%
Medtronic 89.79 0.08 0.09% -29.20%
Mesa Laboratories 205.30 1.36 0.67% -24.42%
Orthofix International 23.47 -0.07 -0.30% -42.02%
Koninklijke Philips 21.05 -0.48 -2.25% -56.66%
Philips 20.18 -0.38 -1.82% -50.44%
PerkinElmer 141.69 -0.54 -0.38% -8.93%
Insulet 222.72 4.78 2.19% -20.84%
Surmodics 37.08 -0.15 -0.40% -31.74%
Thermo Fisher Scientific 538.93 -4.35 -0.80% 4.99%
Tandem Diabetes Care 59.78 0.59 0.99% -39.38%
Trinity Biotech 1.23 0.01 0.41% -56.23%

Indexes Price Day Year
USND 11001 -28.04 -0.25% -24.86%
US2000 1704 -3.50 -0.20% -26.08%

Natus Medical
Natus Medical Incorporated provides healthcare solutions focused on the diagnosis and treatment of central nervous and sensory system disorders for patients of all ages. The Company provides product solutions for three end markets: Neuro, Newborn Care and Hearing & Balance. Its Neuro includes products and services that provide diagnostic, therapeutic and surgical solutions in neurodiagnostics, neurocritical care and neurosurgery. Its Newborn Care includes products and services for newborn care, including hearing screening, brain monitoring, eye imaging, jaundice management and various disposable newborn care supplies. Its Hearing portfolio includes products for hearing assessment and diagnostics and hearing aid fitting, including computer-based audiological, otoneurologic and vestibular instrumentation for hearing care professionals. Its Balance portfolio provides diagnosis and assessment of vestibular and balance disorders.